VSV-G–Targeted RCL Testing: Faster Insights for Lentiviral Vector Safety

VSV-G–Targeted RCL Testing: Faster Insights for Lentiviral Vector Safety

In the fast-growing field of cell and gene therapy (CGT), lentiviral (LV) vectors have emerged as one of the most reliable and efficient gene deli...
VSV-G–Targeted RCL Testing: Faster Insights for Lentiviral Vector Safety

VSV-G–Targeted RCL Testing: Faster Insights for Lentiviral Vector Safety

In the fast-growing field of cell and gene therapy (CGT), lentiviral (LV) vectors have emerged as one of the most reliable and efficient gene deli...
MDCK Influenza Vaccines: Solving the Challenges of Residual DNA QC

MDCK Influenza Vaccines: Solving the Challenges of Residual DNA QC

For over seventy years, the global production of influenza vaccines has relied on a humble, everyday agricultural product: the fertilized chicken ...
From Compendial Compliance to IND Approval: A Regulatory-Ready Rapid Mycoplasma Testing Strategy

From Compendial Compliance to IND Approval: A Regulatory-Ready Rapid Mycoplasma Testing Strategy

  The core conflict in mycoplasma testing is time versus compliance: culture methods take too long, and rapid methods were feared until regulator...
Pichia pastoris Host Cell Protein (HCP) ELISA Kit (36720ES): Double-Antibody Sandwich Capture of Trace Impurities

Pichia pastoris Host Cell Protein (HCP) ELISA Kit (36720ES): Double-Antibody Sandwich Capture of Trace Impurities

 If residual host DNA is the "visible risk," host cell proteins (HCPs) are the silent saboteurs of your Pichia-derived biologics. Here's why—and h...
Plasmid DNA Residual Detection Kit

Plasmid DNA Residual Detection Kit

Plasmid DNA is a core raw material and critical vector for gene therapy, mRNA vaccines, and cell therapy products. From FDA guidelines to the 2025 ...
HCD, HCP, and Mycoplasma: Key Quality Control Considerations in Biopharmaceutical Manufacturing

HCD, HCP, and Mycoplasma: Key Quality Control Considerations in Biopharmaceutical Manufacturing

From cell substrate to final product, effective impurity and contamination control is essential for biologic safety, consistency, and regulatory re...
Advancing Biopharmaceutical Quality Control: Unveiling the Science of HEK293 Residual Detection

Advancing Biopharmaceutical Quality Control: Unveiling the Science of HEK293 Residual Detection

In modern biopharmaceutical manufacturing, ensuring the purity and safety of cell-derived products is paramount. One critical quality attribute is ...
Fast, and Accurate Mycoplasma qPCR Kit (2G)

신제품 출시 | Yeasen: 규정 준수, 빠르고 다재다능한 Mycoplasma qPCR 키트(2G)

최근 몇 년 동안 바이오 의약품의 급속한 발전과 팬데믹 기간 동안 세포 및 유전자 치료제, 그리고 mRNA 백신의 등장으로, 생물학적 제품의 안전성과 신뢰성 확보는 전 세계 정부와 규제 기관의 주요 관심사이자 규제 우선순위가 되었습니다. 마이코플라스마는 흔하지만 ...
High-sensitivity, fg-grade, residual DNA detection kits for quality control of biological products

생물학적 제품의 품질 관리를 위한 고감도, fg 등급, 잔류 DNA 검출 키트

개요 숙주 세포 잔류 DNA는 생물학적 제제의 생산에 관여하는 공정 관련 불순물로, 생물학적 제제의 효과를 떨어뜨릴 뿐만 아니라 감염성이나 종양 형성성과 같은 안전 문제를 일으킬 수도 있습니다. 따라서 다양한 국가의 규제 기관은 생물학적 제제의 잔류 DNA...
MycAway Mycoplasma Real-time qPCR Detection Kit (2G) Validation Report

MycAway Mycoplasma 실시간 qPCR 검출 키트(2G) 검증 보고서

배경 이 보고서에 요약된 데이터는 MycAway TM Mycoplasma Real-time qPCR Detection Kit (2G) 제품에 대해 Yeasen Biotechnology (Shanghai) Co., Ltd.에서 수행했습니다....
CHO Host Cell DNA Residue Detection Kit (3G) Validation Report

CHO 숙주 세포 DNA 잔류물 검출 키트(3G) 검증 보고서

CHO 숙주 세포 DNA 잔류물 검출 키트 ( 3G ) 자격 요약 (Cat No.: 41332 ES60) 배경 이 보고서에 요약된 데이터는 CHO Host Cell DNA Residue Detection Kit(3G) 제품을 위해 Ye...
HEK293 Host Cell DNA Residue Detection Kit (3G) Validation Report

HEK293 숙주 세포 DNA 잔류물 검출 키트(3G) 검증 보고서

HEK293 숙주 세포 DNA 잔류물 검출 키트 ( 3G ) 자격 요약 (Cat No.: 4 1331 ES60) 배경 이 보고서에 요약된 데이터는 Yeasen Biotechnology에서 'HEK293 Host Cell DNA Resid...
E.coli Host Cell DNA Residue Detection Kit (2G) Validation Report

대장균 숙주 세포 DNA 잔류물 검출 키트(2G) 검증 보고서

대장균 숙주세포 DNA 잔류물 검출 키트 ( 2G ) 자격 요약 (Cat No.: 4 1308 ES60) 배경 이 보고서에 요약된 데이터는 Yeasen Biotechnology에서 'E.coli Host Cell DNA Residue ...

문의